<DOC>
	<DOCNO>NCT02566733</DOCNO>
	<brief_summary>Target control infusion remifentanil widely use cardiac surgery , wich perform use Minto model . It derive patient undergo general surgery . However , pharmacokinetics remifentanil change cardiopulmonary bypass . The investigator test whether Minto model target control infusion produce constant plasma remifentanil concentration cardiac surgery .</brief_summary>
	<brief_title>Minto Model Effect Site Mode Target-Controlled Infusion Remifentanil During Cardiopulmonary Bypass</brief_title>
	<detailed_description />
	<mesh_term>Remifentanil</mesh_term>
	<criteria>Adult patient ASA class I~III undergo elective cardiac surgery use cardiopulmonary bypass Patients use target control infusion operation Patients drug/substance abuse Patients use analgesic study start Pregnant woman Patients reject study participation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>remifentanil</keyword>
</DOC>